Choosing Between Vitrification and Slow Freezing — A Practical View for IVF Lab Managers
If you manage an IVF laboratory, the vitrification versus slow freezing question is not really a debate any more for most sample types. The clinical evidence settled it some time ago. What remains is making sure the practical implementation in your laboratory reflects that evidence.
For oocytes and embryos, vitrification is the method supported by ESHRE guidelines and by the survival rate data accumulated over the past two decades. Oocyte survival consistently exceeds 90% with vitrification in competent laboratories. Blastocyst survival reaches 95% or above. The variability that characterised slow freezing outcomes — particularly for oocytes, where spindle sensitivity made results unpredictable — is largely eliminated when the right technique and consumables are used consistently.
The practical requirements for vitrification are straightforward. You need a validated carrier system, vitrification and warming media, and appropriate storage vessels. Consumable standardisation matters more than most laboratory teams initially expect. The CBS HSV Vitrification Kit provides a complete closed system that addresses both the clinical and regulatory requirements in HFEA-licensed centres, and using a validated kit rather than assembling components from multiple suppliers reduces the variables that affect outcome consistency.
Slow freezing remains essential for sperm banking. A controlled-rate freezer is core infrastructure for any laboratory offering sperm cryopreservation, and there is no clinical case for changing this. Most full-service IVF units run both methods and need both capability sets maintained to current standards.
Comments
Post a Comment